← back to search

Nicolas Villain

Centre National de la Recherche Scientifique · FR
Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Functional Brain Connectivity Studies, and Advanced Neuroimaging Techniques and Applications.
h-index
32
citations
5,337
works
180
NIH funding
primary concept
email

Recent publications

The science does not yet support regulatory approval of amyloid‐targeting therapies for Alzheimer's disease based solely on biomarker evidence
Alzheimer s & Dementia 2025cited by 16position: lastdoi
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation
JAMA Neurology 2024cited by 329position: middledoi
Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome
Acta Neuropathologica 2024cited by 12position: middledoi
Dementia prevention in memory clinics: recommendations from the European task force for brain health services
The Lancet Regional Health - Europe 2023cited by 177position: middledoi
Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer’s disease
Brain Communications 2023cited by 53position: middledoi
Association of <i>APOE</i> -Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults
Neurology 2022cited by 24position: middledoi
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
The Lancet Neurology 2021cited by 993position: middledoi
US Food and Drug Administration Approval of Aducanumab—Is Amyloid Load a Valid Surrogate End Point for Alzheimer Disease Clinical Trials?
JAMA Neurology 2021cited by 42position: lastdoi
Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease
NeuroImage Clinical 2013cited by 359position: middledoi
Age effect on the default mode network, inner thoughts, and cognitive abilities
Neurobiology of Aging 2012cited by 130position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2021–2025)Lon S. Schneider · University of Southern California2 papers (2021–2025)Marie‐Claude Potier · Centre National de la Recherche Scientifique2 papers (2022–2024)Douglas Galasko · La Jolla Bioengineering Institute2 papers (2021–2025)Audrey Perrotin · Écologie Marine Tropicale des Océans Pacifique et Indien2 papers (2012–2013)Giovanni B. Frisoni · University of Geneva2 papers (2021–2025)Bruno Dubois · The Neurological Institute2 papers (2021–2022)Gaël Chételat · Friedrich Schiller University Jena2 papers (2012–2013) · 2 papers (2012–2013)Renaud La Joie · University Memory and Aging Center2 papers (2012–2013)Kaj Blennow · First Affiliated Hospital of Anhui Medical University2 papers (2021–2024)Marie‐Odile Habert · Centre National de la Recherche Scientifique1 papers (2022–2022) · 1 papers (2012–2012)Charles Duyckaerts · Centre National de la Recherche Scientifique1 papers (2024–2024) · 1 papers (2024–2024)Howard Feldman · University of San Diego1 papers (2021–2021)Robert Howard · University College London1 papers (2023–2023)André Strydom · Universitat Autònoma de Barcelona1 papers (2024–2024)Lev Stimmer · Allen Institute for Brain Science1 papers (2024–2024) · 1 papers (2012–2012)